Colin Zadikoff
Neurology · Cincinnati, OHNPI 1497865406
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.2% of the total across 55 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for neurology clinicians in OH, where the typical reported total is $970.
Across 55 payments — averaging $17.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$179
- UCB, Inc.$85
- Novartis$75
- Greenwich Biosciences, Inc.$61
- Eisai Inc.$58
- Acorda Therapeutics, Inc$54
- plus $425 from 17 others
Across 7 payments — averaging $3003.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$17K
- Novartis$4K
What the payments were for
- Speaking & faculty fees$546%
- Food & beverage$88394%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 7 | $179 |
| UCB, Inc. | 5 | $85 |
| Novartis | 5 | $75 |
| Greenwich Biosciences, Inc. | 1 | $61 |
| Eisai Inc. | 3 | $58 |
| Acorda Therapeutics, Inc | 4 | $54 |
| Sanofi | 3 | $52 |
| CSL Behring | 3 | $44 |
| AbbVie(2 entities) | 3 | $41 |
| Sunovion Pharmaceuticals Inc. | 3 | $40 |
| Teva Pharmaceuticals USA, Inc. | 3 | $38 |
| Lundbeck LLC | 2 | $34 |
| Adamas Pharmaceuticals, Inc. | 2 | $25 |
| Supernus Pharmaceuticals, Inc. | 2 | $23 |
| AstraZeneca | 1 | $19 |
| Saol Therapeutics Inc. | 1 | $17 |
| Promius Pharma LLC | 1 | $16 |
| Aquestive Therapeutics, Inc. | 1 | $14 |
| Grifols USA, LLC | 1 | $14 |
| Amgen | 1 | $13 |
| Pfizer | 1 | $13 |
| Genentech USA, Inc. | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$937 in reported general payments places this provider in the 45th percentile of 702 neurology providers in Ohio.
Other neurology in Cincinnati
- Aram ZabetiCincinnati$1.6M
- Brandon ForemanCincinnati$385K
- Alberto EspayCincinnati$351K
- Michael PriviteraCincinnati$243K
- Brian MoseleyCincinnati$220K
- Zainab ContractorCincinnati$181K
- Reena ShahCincinnati$180K
- Marsha SmithCincinnati$178K
- David SchmerlerCincinnati$162K
- Hani KushlafCincinnati$115K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.